Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 3
R&D Momentum
78/100
Pipeline Velocity
41/100
Trial Completion Rate
89/100
Pipeline Concentration
28/100
Pipeline Freshness
0/100
Strategic Signals
Activity
Last 14 days
The Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism
Evaluation of Adults With Endocrine-Related Conditions
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation &Amp;Amp;Amp;Amp; Metabolic Rate
Mechanisms in Hepatic Lipid Metabolism in Alcohol Use Disorder: From Genomics, Transcriptomics to Metabolomics
Focal Segmental Glomerulosclerosis Clinical Trial
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)